摘要
三链形成肽核酸(PNAs) 通过改变螺旋结构的特定位点形成,以刺激基因组供体DNA的重组来促进基因编辑,进而刺激DNA修复。然而,三链形成设计的PNAs是仅限于同型嘌呤的序列位点。在此,我们描述了一个新的方法,γ位由miniPEG替换的新一代的单链γ肽核酸(γPNAs) 在混合序列位点可以把小鼠骨髓基因组DNA作为靶点,以诱导靶向基因编辑。除了加强结合力,γPNAs还具有增加溶解度的特性,改进配方为聚乳糖-羟基乙酸共聚物纳米粒以便有效的细胞内分散。单链的γ肽核酸诱导体外治疗的小鼠骨髓细胞编码区的靶向基因频率为0.8%,体内静脉注射的基因频率为0.1%,没有可检测的毒性。这些结果表明,γPNAs可能提供一个新的基于没有序列识别限制的沃森-克里克理论来诱导基因编辑的工具。
关键词: β-球蛋白,基因组编辑,绿色荧光蛋白,纳米颗粒,聚乳酸-羟基乙酸共聚物,肽核酸。
Current Gene Therapy
Title:Single-Stranded γPNAs for In Vivo Site-Specific Genome Editing via Watson-Crick Recognition
Volume: 14 Issue: 5
Author(s): Raman Bahal, Elias Quijano, Nicole A. McNeer, Yanfeng Liu, Dinesh C. Bhunia, Francesco Lopez-Giraldez, Rachel J. Fields, William M. Saltzman, Danith H. Ly and Peter M. Glazer
Affiliation:
关键词: β-球蛋白,基因组编辑,绿色荧光蛋白,纳米颗粒,聚乳酸-羟基乙酸共聚物,肽核酸。
摘要: Triplex-forming peptide nucleic acids (PNAs) facilitate gene editing by stimulating recombination of donor DNAs within genomic DNA via site-specific formation of altered helical structures that further stimulate DNA repair. However, PNAs designed for triplex formation are sequence restricted to homopurine sites. Herein we describe a novel strategy where next generation single-stranded gamma PNAs (γPNAs) containing miniPEG substitutions at the gamma position can target genomic DNA in mouse bone marrow at mixed-sequence sites to induce targeted gene editing. In addition to enhanced binding, γPNAs confer increased solubility and improved formulation into poly(lactic-co-glycolic acid) (PLGA) nanoparticles for efficient intracellular delivery. Single-stranded γPNAs induce targeted gene editing at frequencies of 0.8% in mouse bone marrow cells treated ex vivo and 0.1% in vivo via IV injection, without detectable toxicity. These results suggest that γPNAs may provide a new tool for induced gene editing based on Watson-Crick recognition without sequence restriction.
Export Options
About this article
Cite this article as:
Bahal Raman, Quijano Elias, McNeer A. Nicole, Liu Yanfeng, Bhunia C. Dinesh, Lopez-Giraldez Francesco, Fields J. Rachel, Saltzman M. William, Ly H. Danith and Glazer M. Peter, Single-Stranded γPNAs for In Vivo Site-Specific Genome Editing via Watson-Crick Recognition, Current Gene Therapy 2014; 14 (5) . https://dx.doi.org/10.2174/1566523214666140825154158
DOI https://dx.doi.org/10.2174/1566523214666140825154158 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Melatonin Signaling in Health and Disease
Melatonin regulates a multitude of physiological functions, including circadian rhythms, acting as a scavenger of free radicals, an anti-inflammatory agent, a modulator of mitochondrial homeostasis, an antioxidant, and an enhancer of nitric oxide bioavailability. AANAT is the rate-limiting enzyme responsible for converting serotonin to NAS, which is further converted to ...read more
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers.
Programmed cell death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
The now and future of gene transfer technologies
Gene and cell therapies rely on a gene delivery system which is safe and effective. Both viral and non-viral vector systems are available with specific pros and cons. The choice of a vector system is largely dependent on the application which is a balance between target tissue/disease and safety, efficacy ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Aldose Reductase: A Novel Target for Cardioprotective Interventions
Current Drug Targets An Update on Management of Acute and Chronic Open Wounds: The Importance of Moist Environment in Optimal Wound Healing
Medicinal Chemistry Reviews - Online (Discontinued) Non-Insulin Dependent Diabetes Mellitus: Present Therapies and New Drug Targets&#
Mini-Reviews in Medicinal Chemistry Double-Edged Effects of Arsenic Compounds: Anticancer and Carcinogenic Effects
Current Drug Metabolism Design and Development of Preservative Free Herbal Dosage Forms
The Natural Products Journal Enhanced Gene Delivery and/or Efficacy by Functional Peptide and Protein
Current Topics in Medicinal Chemistry Irbesartan Inhibits Albumin-Elicited Proximal Tubular Cell Apoptosis and Injury In Vitro
Protein & Peptide Letters Statins for Early Stage Chronic Kidney Disease: An Overview of Reviews
Cardiovascular & Hematological Disorders-Drug Targets Neonatal Hypertension: An Underdiagnosed Condition, A Review Article
Current Hypertension Reviews Gene Expression Profiles in Human Autoimmune Disease
Current Pharmaceutical Design Alstrom Syndrome: Genetics and Clinical Overview
Current Genomics Recent Advances in Obesity Pharmacotherapy
Current Clinical Pharmacology Sirolimus Early Graft Nephrotoxicity: Clinical and Experimental Data
Current Drug Safety The HIV-1 Rev Binding Family of Proteins: The Dog Proteins as a Study Model
Endocrine, Metabolic & Immune Disorders - Drug Targets High-Throughput Evaluation of CYP1A1 and 2B1 Induction in Rat Liver Slices Using a Semi-Automated System
Drug Metabolism Letters High Risk of One-year Stroke Recurrence in Patients with Younger Age and Prior History of Ischemic Stroke
Current Neurovascular Research Structure-Based Drug Design of Novel MARK-3 Inhibitors in Cancer
Current Bioactive Compounds Challenges in the Correct Assessment of a Case of Aggressive Thyroid Carcinoma with Synchronous Breast Cancer: A Case Report and Review of the Literature of Essential Role of Radiopharmaceuticals
Current Radiopharmaceuticals Biohybrid Membrane Systems for Testing Molecules and Stem Cell Therapy in Neuronal Tissue Engineering
Current Pharmaceutical Design From Laptop to Benchtop to Bedside: Structure-based Drug Design on Protein Targets
Current Pharmaceutical Design